PUGNAc

PUGNAc
Clinical data
Pregnancy; category	?;
Routes of; administration	Oral
Identifiers
	IUPAC name O-(2-Acetamido-2-deoxy-D-glucopyranosylidene)amino N-phenyl carbamate;
CAS Number	132489-69-1 ;
PubChem CID	9576811;
UNII	AWZ7VE64B6;
CompTox Dashboard (EPA)	DTXSID101117756 ;
Chemical and physical data
Formula	C15H19N3O7
Molar mass	353.33 g·mol−1
	(verify)

PUGNAc is a 1,5-hydroximolactone, acting as an inhibitor of a variety of N-acetylhexosaminidases.^[1] It was long thought that increased levels of O-GlcNAc in human cells lead to Type II diabetes. O-GlcNAc levels were artificially raised with PUGNAc, which inhibits O-GlcNAcase, a beta-exo-N-acetylhexosaminidase which cleaves beta-O-linked-N-acetylglucosamine residues from glycoproteins. As a result of this inhibition, a type II diabetic phenotype was observed. Recent pharmacological studies using a more selective O-GlcNAcase inhibitor did not see this effect. However, genetic manipulation of O-GlcNAc levels is consistent with the effects observed by PUGNAc, namely insulin resistance upon elevation of O-GlcNAc levels.

Fictional references

PUGNAc was used by Michael Scofield in the television series Prison Break to keep his blood sugar level high to appear diabetic.^[2]

References

^ Cox NJ, Meister TR, Boyce M (March 2017). "Chemical biology of O-GlcNAc glycosylation". In Tan Z, Wang LX (eds.). Chemical biology of glycoproteins. United Kingdom: Royal Society of Chemistry. doi:10.1039/9781782623823-00094. ISBN 978-1-78801-122-8.
^ Season 1, episode 1

External links

Research paper

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.

[1] Cox NJ, Meister TR, Boyce M (March 2017). "Chemical biology of O-GlcNAc glycosylation". In Tan Z, Wang LX (eds.). Chemical biology of glycoproteins. United Kingdom: Royal Society of Chemistry. doi:10.1039/9781782623823-00094. ISBN 978-1-78801-122-8.

[2] Season 1, episode 1

[1]

[2]